News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rockwell Medical (RMTI) To Participate At Craig-Hallum Institutional Investor Conference Wednesday, May 28, 2014 In Minneapolis, MN


5/23/2014 10:11:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WIXOM, Mich., May 22, 2014 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it will participate at the 11th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 28, 2014 at the Minneapolis Marriott City Center Hotel, Minneapolis, MN. Founder and CEO, Rob Chioini and CMO, Dr. Ray Pratt will be discussing Rockwell's business initiatives and lead drug candidate Triferic, the Company's late-stage investigational iron-replacement drug for the treatment of iron deficiency in chronic kidney disease patients receiving hemodialysis.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES